Litescu M, Marincas A, Mitroi G, Plesea I, Strambu V, Grigorean V
Rom J Morphol Embryol. 2023; 64(3):363-378.
PMID: 37867354
PMC: 10720943.
DOI: 10.47162/RJME.64.3.08.
Han Z, Feng Y, Deng Y, Tang Z, Cai S, Zhuo Y
Transl Androl Urol. 2022; 11(7):914-928.
PMID: 35958903
PMC: 9360515.
DOI: 10.21037/tau-21-1148.
Kobayashi H, Kosaka T, Mikami S, Kimura T, Hongo H, Kosugi M
BMJ Open. 2021; 11(11):e056439.
PMID: 34819292
PMC: 8614138.
DOI: 10.1136/bmjopen-2021-056439.
Bhargava H, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S
Clin Cancer Res. 2020; 26(8):1915-1923.
PMID: 32139401
PMC: 7165025.
DOI: 10.1158/1078-0432.CCR-19-2659.
Yang Q, Chen J, Zhu Y, Xu Z
J Cancer. 2019; 10(19):4532-4539.
PMID: 31528217
PMC: 6746123.
DOI: 10.7150/jca.30788.
The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis.
Li H, Zhong A, Li S, Meng X, Wang X, Xu F
Sci Rep. 2017; 7(1):4915.
PMID: 28687755
PMC: 5501852.
DOI: 10.1038/s41598-017-05280-6.
Prostate cancer stroma: an important factor in cancer growth and progression.
Kruslin B, Ulamec M, Tomas D
Bosn J Basic Med Sci. 2015; 15(2):1-8.
PMID: 26042506
PMC: 4469930.
DOI: 10.17305/bjbms.2015.449.
Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.
Meseure D, Alsibai K, Nicolas A
Cancer Microenviron. 2014; 7(3):95-115.
PMID: 25523234
PMC: 4275542.
DOI: 10.1007/s12307-014-0158-2.
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
Pertega-Gomes N, Vizcaino J, Attig J, Jurmeister S, Lopes C, Baltazar F
BMC Cancer. 2014; 14:352.
PMID: 24886074
PMC: 4039335.
DOI: 10.1186/1471-2407-14-352.
Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.
Montico F, Akemi Kido L, Hetzl A, Lorencini R, Candido E, Cagnon V
Histochem Cell Biol. 2014; 142(3):269-84.
PMID: 24562790
DOI: 10.1007/s00418-014-1193-2.
New cast for a new era: preclinical cancer drug development revisited.
Herter-Sprie G, Kung A, Wong K
J Clin Invest. 2013; 123(9):3639-45.
PMID: 23999436
PMC: 3754257.
DOI: 10.1172/JCI68340.
Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.
Wen S, Niu Y, Lee S, Chang C
Cancer Treat Rev. 2013; 40(1):31-40.
PMID: 23993415
PMC: 3833078.
DOI: 10.1016/j.ctrv.2013.07.008.
Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
Gurusamy D, Gray J, Pathrose P, Kulkarni R, Finkleman F, Waltz S
Cancer Res. 2013; 73(6):1752-63.
PMID: 23328584
PMC: 3602275.
DOI: 10.1158/0008-5472.CAN-12-2474.
The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.
Jiang Q, Han B, Zhao F, Hong Y, Xia S
Asian J Androl. 2011; 13(6):798-805.
PMID: 21765438
PMC: 3739557.
DOI: 10.1038/aja.2011.22.
Normal prostate-derived stromal cells stimulate prostate cancer development.
Peng Y, Zhou J, Gao Y, Li Y, Wang H, Zhang M
Cancer Sci. 2011; 102(9):1630-5.
PMID: 21672088
PMC: 11159478.
DOI: 10.1111/j.1349-7006.2011.02008.x.
Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.
Sun X, He H, Xie Z, Qian W, Zhau H, Chung L
In Vitro Cell Dev Biol Anim. 2010; 46(6):538-46.
PMID: 20383666
PMC: 2875468.
DOI: 10.1007/s11626-010-9309-z.
Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?.
Gonda T, Varro A, Wang T, Tycko B
Semin Cell Dev Biol. 2009; 21(1):2-10.
PMID: 19840860
PMC: 3531978.
DOI: 10.1016/j.semcdb.2009.10.001.
The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M, Gillespie J, Hewitt S, Chen Y, Maeda S, Stein I
PLoS One. 2009; 4(8):e6695.
PMID: 19690611
PMC: 2723911.
DOI: 10.1371/journal.pone.0006695.
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
Grubb R, Deng J, Pinto P, Mohler J, Chinnaiyan A, Rubin M
J Proteome Res. 2009; 8(6):3044-54.
PMID: 19275204
PMC: 2790378.
DOI: 10.1021/pr8009337.
Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.
Zhao H, Peehl D
Prostate. 2009; 69(9):991-1000.
PMID: 19267366
PMC: 2736596.
DOI: 10.1002/pros.20946.